Iron deficiency impacts prognosis but less exercise capacity in heart failure with preserved ejection fraction

被引:25
作者
Barandiaran Aizpurua, Arantxa [1 ,2 ]
Sanders-van Wijk, Sandra [1 ,2 ]
Brunner-La Rocca, Hans-Peter [1 ,2 ]
Henkens, Michiel T. H. M. [1 ,2 ]
Weerts, Jerremy [1 ,2 ]
Spanjers, Mireille H. A. [1 ]
Knackstedt, Christian [1 ,2 ]
van Empel, Vanessa P. M. [1 ,2 ]
机构
[1] Maastricht Univ, Med Ctr MUMC, Dept Cardiol, PO 5800, NL-6202AZ Maastricht, Netherlands
[2] Maastricht Univ, Med Ctr MUMC, Cardiovasc Res Inst Maastricht CARIM, Maastricht, Netherlands
关键词
Iron deficiency; Heart failure with preserved ejection fraction; Exercise capacity; PULMONARY-HYPERTENSION; FERRIC CARBOXYMALTOSE; DYSFUNCTION; PREVALENCE; THERAPY; PRESSURE; PREDICTS; ANEMIA; WOMEN;
D O I
10.1002/ehf2.13204
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims Whether and how iron deficiency (ID) impacts patients with heart failure (HF) with preserved ejection fraction (HFpEF) remain unclear. The aim of our study was to investigate the impact of ID on functional status, exercise capacity, and prognosis in HFpEF. Methods and results The study population consisted of 300 HFpEF patients. ID was defined as serum ferritin <100 mu g/L or 100-300 mu g/L and transferrin-saturation <20%. Baseline functional status, quality of life (HADS score and EQ 5D index), 6 min walking test, echocardiography, and outcome (all-cause mortality and combined all cause-mortality and HF hospitalization) were evaluated. ID was found in 159 (53%) patients. Patients with ID had a worse prognosis with a higher combined endpoint of all-cause mortality and HF hospitalization after 4 years of follow-up (log rank = 0.008). Pulmonary hypertension, depression, and thyroid disease were more prevalent in the ID group. Multivariable analysis showed that ID was independently associated with body mass index (P = 0.003), pulmonary hypertension (P = 0.008), and thyroid disease (P = 0.01). Although patients with ID had a lower exercise capacity compared with patients without ID (393 m [294-455] vs. 344 m [260-441], P = 0.008), there was no significant correlation after multivariable correction for age, BMI, NT-proBNP, DM, and depression. Conclusions Heart failure with preserved ejection fraction patients with ID have a worse prognosis and impaired exercise capacity compared with those without ID. However, although a trend was observed, after multivariable correction ID was no longer significantly associated with a reduced exercise capacity. This reflects that impaired exercise capacity in HFpEF is complex and seems multifactorial. Interestingly, pulmonary hypertension was an independent predictor of both ID and exercise capacity.
引用
收藏
页码:1304 / 1313
页数:10
相关论文
共 38 条
[1]   Ferric Carboxymaltose in Patients with Heart Failure and Iron Deficiency. [J].
Anker, Stefan D. ;
Comin Colet, Josep ;
Filippatos, Gerasimos ;
Willenheimer, Ronnie ;
Dickstein, Kenneth ;
Drexler, Helmut ;
Luescher, Thomas F. ;
Bart, Boris ;
Banasiak, Waldemar ;
Niegowska, Joanna ;
Kirwan, Bridget-Anne ;
Mori, Claudio ;
Rothe, Barbara von Eisenhart ;
Pocock, Stuart J. ;
Poole-Wilson, Philip A. ;
Ponikowski, Piotr .
NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (25) :2436-2448
[2]  
[Anonymous], 2020, Am J Respir Crit Care Med, V201, P393, DOI 10.1164/rccm.v201erratum1
[3]   Iron deficiency impacts prognosis but less exercise capacity in heart failure with preserved ejection fraction [J].
Barandiaran Aizpurua, Arantxa ;
Sanders-van Wijk, Sandra ;
Brunner-La Rocca, Hans-Peter ;
Henkens, Michiel T. H. M. ;
Weerts, Jerremy ;
Spanjers, Mireille H. A. ;
Knackstedt, Christian ;
van Empel, Vanessa P. M. .
ESC HEART FAILURE, 2021, 8 (02) :1304-1313
[4]   Iron deficiency in heart failure with preserved ejection fraction: a systematic review and meta-analysis [J].
Beale, Anna L. ;
Warren, Josephine Lillian ;
Roberts, Nia ;
Meyer, Philippe ;
Townsend, Nick P. ;
Kaye, David .
OPEN HEART, 2019, 6 (01)
[5]   Iron deficiency in patients with heart failure with preserved ejection fraction and its association with reduced exercise capacity, muscle strength and quality of life [J].
Bekfani, Tarek ;
Pellicori, Pierpaolo ;
Morris, Daniel ;
Ebner, Nicole ;
Valentova, Miroslava ;
Sandek, Anja ;
Doehner, Wolfram ;
Cleland, John G. ;
Lainscak, Mitja ;
Schulze, P. Christian ;
Anker, Stefan D. ;
von Haehling, Stephan .
CLINICAL RESEARCH IN CARDIOLOGY, 2019, 108 (02) :203-211
[6]   Differences in Clinical Profile and Outcomes of Low Iron Storage vs Defective Iron Utilization in Patients With Heart Failure Results From the DEFINE-HF and BIOSTAT-CHF Studies [J].
Beverborg, Niels Grote ;
van der Wal, Haye H. ;
Klip, Usbrand T. ;
Klip, Ijsbrand T. ;
Anker, Stefan D. ;
Cleland, John ;
Dickstein, Kenneth ;
van Veldhuisen, Dirk J. ;
Voors, Adriaan A. ;
van der Meer, Peter .
JAMA CARDIOLOGY, 2019, 4 (07) :696-701
[7]   Iron Homeostasis and Pulmonary Hypertension Iron Deficiency Leads to Pulmonary Vascular Remodeling in the Rat [J].
Cotroneo, Emanuele ;
Ashek, Ali ;
Wang, Lei ;
Wharton, John ;
Dubois, Olivier ;
Bozorgi, Sophie ;
Busbridge, Mark ;
Alavian, Kambiz N. ;
Wilkins, Martin R. ;
Zhao, Lan .
CIRCULATION RESEARCH, 2015, 116 (10) :1680-1690
[8]   ATS statement: Guidelines for the six-minute walk test [J].
Crapo, RO ;
Casaburi, R ;
Coates, AL ;
Enright, PL ;
MacIntyre, NR ;
McKay, RT ;
Johnson, D ;
Wanger, JS ;
Zeballos, RJ ;
Bittner, V ;
Mottram, C .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2002, 166 (01) :111-117
[9]   The iron exporter ferroportin/Slc40a1 is essential for iron homeostasis [J].
Donovan, A ;
Lima, CA ;
Pinkus, JL ;
Pinkus, GS ;
Zon, LI ;
Robine, S ;
Andrews, NC .
CELL METABOLISM, 2005, 1 (03) :191-200
[10]   Iron Therapy in Patients with Heart Failure and Iron Deficiency: Review of Iron Preparations for Practitioners [J].
Drozd, Marcin ;
Jankowska, Ewa A. ;
Banasiak, Waldemar ;
Ponikowski, Piotr .
AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2017, 17 (03) :183-201